Follow
Tumor
Tumor: is an abnormal mass of tissue that may be solid or fluid-filled. A tumor is not the same as cancer. Although, some tumors can develop into cancers. A tumor is a kind of lump or swelling and does not necessarily pose a health threat.
NOV 18, 2025 | 10:00 AM
Perineural invasion (PNI) is a well-established factor of poor prognosis in multiple cancer types, yet its mechanism remains unclear. By using a multi-omics approach, overlay of multiple spa...
NOV 18, 2025 | 8:00 AM
Transcriptomics represents a critical discipline in cancer research, enabling comprehensive mapping of gene expression profiles and the identification of fusion genes implicated in tumor dev...
NOV 12, 2025 | 7:00 AM
In recognition of Pancreatic Cancer Awareness Month, join us to explore how cutting-edge technologies are transforming our understanding of pancreatic ductal adenocarcinoma (PDAC), one of th...
OCT 29, 2025 7:00 AM PT
This presentation explores the scientific rationale, preclinical validation, and early clinical translation of STAR-LLD—a novel, continuous low-dose percutaneous lenalidomide delivery...
OCT 28, 2025 | 7:00 AM
C.E. CREDITS
In recognition of Breast Cancer Awareness Month, join us for a live webinar to uncover the complexity of tumor biology and the surprising resilience of normal tissue. This event will feature...
OCT 21, 2025 | 7:00 AM
Glioblastoma (GBM) is an aggressive brain tumor characterized by marked intra- and inter-tumoral heterogeneity and inevitable recurrence. Although extracranial metastasis is rare, circulatin...
OCT 15, 2025 | 10:00 AM
The Cancer Gene Census (CGC) is a widely used module within the Catalogue Of Somatic Mutations In Cancer (COSMIC) that comprises an ongoing effort to catalogue and describe all genes with ca...
OCT 01, 2025 | 12:00 PM
The next leap in oncology therapeutics demands speed, precision, and rapid molecular innovation — and AI-driven antibody design (AIDD) is beginning to deliver. In this talk, we will un...
OCT 01, 2025 | 7:30 AM
C.E. CREDITS
Non-small cell lung cancer (NSCLC) accounts for more deaths than colon, breast, and prostate cancers combined. Of patients with NSCLC, 20% initially present with stage I or II disease, for w...
AUG 27, 2025 | 10:00 AM
C.E. CREDITS
Discover how global leaders are advancing equitable access to liquid biopsy with MSK-ACCESS® & SOPHiA DDM™ in this expert-led webinar....
JUN 25, 2025 | 11:00 PM
Learn how blood-based multiomics reveals tumor-specific biomarkers in pediatric cancers, aiding personalized immunotherapy-without invasive biopsies....
JUN 18, 2025 | 8:00 AM
In today's fast-paced research environment, you need cutting-edge tools that push the boundaries of cellular analysis. Spectral flow cytometry and spectral imaging technologies offer unprece...
JUN 11, 2025 | 8:00 AM
Advances in tissue-based technology in the past few years have created unprecedented opportunities to identify biomarkers of disease processes, especially within oncology by using multi-omic...
JUN 10, 2025 | 8:00 AM
Bispecific antibodies (bsAbs) represent a versatile and increasingly important class of targeted therapeutics, designed to bind two distinct sites — either two different epitopes on th...
MAY 28, 2025 | 10:00 AM
C.E. CREDITS
As oncology care continues to advance, laboratories are increasingly seeking solutions that offer high-impact, decentralized, and accurate genomic testing. The third session of the Precision...
MAY 14, 2025 | 11:00 AM
Interpreting genomic test results for cancer care remains a significant challenge, with variability in turnaround times, reporting standards, and clinical utility impacting patient outcomes....
On Demand
LGC offers a comprehensive portfolio of reference standards and scientific tools for a wide range of disciplines. The focus of this talk will be on reference materials for clinical NGS produ...
MAY 13, 2025 | 9:00 AM
Immune checkpoint blockade (ICB) targeting T cells has enhanced clinical outcomes in patients with renal and bladder cancers; however, response rates remain limited, particularly in cases of...
On Demand
C.E. CREDITS
Clinical effectiveness of immune therapies of solid tumors requires a) the induction or expansion of T cells able of recognizing multiple variants of cancer cells present in each cancer pati...
